Trials Bolster Case for Preemptive Use of HIV Drugs to Reduce Transmission Rates

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American


Cross-posted from Nature Medicine's Spoonful of Medicine blog

Results from two trials released today provide the first evidence that taking antiretroviral drugs can prevent HIV infection among heterosexual men and women.

The preventative strategy, known as pre-exposure prophylaxis (PrEP), was first shown to be effective among gay men. But PrEP suffered a setback in April when a study testing the drug Truvada among women in Africa had to be halted prematurely owing to lack of efficacy. The new trial data, however, shows that the approach has broad potential in the quest to prevent HIV transmission, according to experts in the field.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


“This is the first strong, compelling evidence that PrEP can work in this population,” said Kevin Fenton, director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention at the US Centers for Disease Control and Prevention (CDC), during a press briefing earlier today. “It’s a major milestone.”

Continue reading on Nature Medicine's blog >>

Hannah Waters is a science writer fascinated by the natural world, the history of its study, and the way people think about nature. On top of science blogging, she runs the Smithsonian's Ocean Portal, a marine biology education website, and is science editor for Ladybits.

Hannah is a child of the internet, who coded HTML frames on her Backstreet Boys fanpage when she was in middle school. Aptly, she rose to professional science writing through blogging (originally on Wordpress) and tweeting profusely. She's written for The Scientist, Nature Medicine, Smithsonian.com, and others.

Before turning to full-time writing, Hannah wanted to be an oceanographer or a classicist, studying Biology and Latin at Carleton College in Northfield, Minnesota. She's done ecological research on marine food webs, shorebird conservation, tropical ecology and grassland ecosystems. She worked as a lab technician at the University of Pennsylvania studying molecular biology and the epigenetics of aging. And, for a summer, she manned a microphone and a drink shaker on a tour boat off the coast of Maine, pointing out wildlife and spouting facts over a loudspeaker while serving drinks.

Email her compliments, complaints and tips at culturingscience at gmail dot com.

More by Hannah Waters

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe